相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy
Shan Cao et al.
ACTA PHARMACOLOGICA SINICA (2012)
Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial
Ling Wang et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors
Daniel Sifrim et al.
GUT (2012)
Effect of CYP2C19 Genetic Polymorphism on Pharmacokinetics and Pharmacodynamics of a New Proton Pump Inhibitor, Ilaprazole
Hoon Cho et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Acid inhibition effect of ilaprazole on Helicobacter pylori-negative healthy volunteers: An open randomized cross-over study
Yi Qi Du et al.
JOURNAL OF DIGESTIVE DISEASES (2012)
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients
Edoardo Savarino et al.
JOURNAL OF GASTROENTEROLOGY (2012)
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
Nicola de Bortoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5
Kyung-Ah Seo et al.
XENOBIOTICA (2012)
Overweight is a risk factor for both erosive and non-erosive reflux disease
Edoardo Savarino et al.
DIGESTIVE AND LIVER DISEASE (2011)
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease
Edoardo Savarino et al.
DIGESTIVE AND LIVER DISEASE (2011)
Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD The LOTUS Randomized Clinical Trial
Jean-Paul Galmiche et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A New PPI, Ilaprazole Compared With Omeprazole in the Treatment of Duodenal Ulcer A Randomized Double-Blind Multicenter Trial
Ling Wang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance-pH Off Therapy
Edoardo Savarino et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Identification of ilaprazole metabolites in human urine by HPLC-ESI-MS/MS and HPLC-NMR experiments
Gan Zhou et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Edoardo Savarino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease
E. Savarino et al.
GUT (2009)
Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers
Khek Yu Ho et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety
Vincenzo Savarino et al.
PHARMACOLOGICAL RESEARCH (2009)
Effect of CYP2C19*2 and*17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
Nicole G. Hunfeld et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes
Yalin Li et al.
CLINICA CHIMICA ACTA (2008)
Proton pump inhibitors - Do differences in pharmacokinetics translate into differences in clinical outcomes?
Kwong Ming Fock et al.
CLINICAL PHARMACOKINETICS (2008)
Yield of 24-hour esophageal pH and Bilitec monitoring in patients with persisting symptoms on PPI therapy
George Karamanolis et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Functional heartburn and non-erosive reflux disease
Vincenzo Savarino et al.
DIGESTIVE DISEASES (2007)
The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
Nimish Vakil et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Nonacid reflux in patients with chronic cough on acid-suppressive therapy
Radu Tutuian et al.
CHEST (2006)
Review article: the clinical pharmacology of proton pump inhibitors
G Sachs et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Acid suppression therapy: Where do we go from here?
Carmelo Scarpignato et al.
DIGESTIVE DISEASES (2006)
The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications
JM Bautista et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip
CH Liu et al.
PHARMACOGENOMICS (2005)
Epidemiology of gastrooesophageal reflux disease: A systematic review
J Dent et al.
GUT (2005)
Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring
D Sifrim et al.
GUT (2005)
CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population
YF Hu et al.
CLINICA CHIMICA ACTA (2005)
The role of esophageal pH monitoring in symptomatic patients on PPI therapy
S Charbel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux - Literature review
P Zentilin et al.
DIGESTIVE AND LIVER DISEASE (2004)
CYPC19 polymorphism and proton pump inhibitors
U Klotz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2004)
Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors - overview and clinical implications
M Robinson
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Pharmacogenetics of the proton pump inhibitors: A systematic review
E Chong et al.
PHARMACOTHERAPY (2003)
Esomeprazole - enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion
P Lindberg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Review of esomeprazole in the treatment of acid disorders
DA Johnson
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Proton pump inhibitors - differences emerge in hepatic metabolism
KEL McColl et al.
DIGESTIVE AND LIVER DISEASE (2002)
The genetic determinants of the CYP3A5 polymorphism
E Hustert et al.
PHARMACOGENETICS (2001)
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole
T Andersson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Comparison of IY81149 with omeprazole in rat reflux oesophagitis
BJ Kil et al.
JOURNAL OF AUTONOMIC PHARMACOLOGY (2000)
Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors
CAM Stedman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease
AP Periclou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
